

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
In a move that public health advocates are calling "irresponsible and frightening," the U.S. Food and Drug Association on Friday cleared the experimental release of genetically modified mosquitoes in Key Haven, Florida.
Pivoting off of the recent news that there is an outbreak of the mosquito-borne Zika virus that has infected over a dozen people in Miami's Wynwood neighborhood, the UK-based developers of the genetically modified organism (GMO) reportedly also called on the FDA to grant emergency authorization to release the insects in Miami.
Oxitec, which produces other GMO products like "Arctic" apples and "AquaBounty" salmon, has developed what they describe as "self-limiting mosquitoes," genetically engineered to die before reaching adulthood.
As the company explains, Oxitec has genetically engineered male mosquitoes--known as OX513A males--which it will release into the wild to mate with native female Aedes aegypti, which bite and can potentially spread disease. Their offspring die off, reducing the population.
"Releasing GMO mosquitoes into the environment without long term environmental impact studies is irresponsible and frightening," said Zen Honeycutt, director of the anti-GMO group Moms Across America, in a statement on Saturday. "What about the creatures who eat the mosquitoes and all the life forms up the food chain? The impact could be irreversible... Allowing uncontrollable genetically altered life forms into the wild is not justified."
The Key Haven trial would run for between six and 22 months and the company said it could release anywhere from 20 to 100 mosquitoes per person on the island.
However, they must contend with strong local opposition first.
Residents of Key Haven will have the chance to vote in November on a non-binding ballot measure on the GMO trial, and a majority of the community's commissioners said they would abide by the will of the voters. And over 168,000 people have signed a petition calling on government officials to reject the trial.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
In a move that public health advocates are calling "irresponsible and frightening," the U.S. Food and Drug Association on Friday cleared the experimental release of genetically modified mosquitoes in Key Haven, Florida.
Pivoting off of the recent news that there is an outbreak of the mosquito-borne Zika virus that has infected over a dozen people in Miami's Wynwood neighborhood, the UK-based developers of the genetically modified organism (GMO) reportedly also called on the FDA to grant emergency authorization to release the insects in Miami.
Oxitec, which produces other GMO products like "Arctic" apples and "AquaBounty" salmon, has developed what they describe as "self-limiting mosquitoes," genetically engineered to die before reaching adulthood.
As the company explains, Oxitec has genetically engineered male mosquitoes--known as OX513A males--which it will release into the wild to mate with native female Aedes aegypti, which bite and can potentially spread disease. Their offspring die off, reducing the population.
"Releasing GMO mosquitoes into the environment without long term environmental impact studies is irresponsible and frightening," said Zen Honeycutt, director of the anti-GMO group Moms Across America, in a statement on Saturday. "What about the creatures who eat the mosquitoes and all the life forms up the food chain? The impact could be irreversible... Allowing uncontrollable genetically altered life forms into the wild is not justified."
The Key Haven trial would run for between six and 22 months and the company said it could release anywhere from 20 to 100 mosquitoes per person on the island.
However, they must contend with strong local opposition first.
Residents of Key Haven will have the chance to vote in November on a non-binding ballot measure on the GMO trial, and a majority of the community's commissioners said they would abide by the will of the voters. And over 168,000 people have signed a petition calling on government officials to reject the trial.
In a move that public health advocates are calling "irresponsible and frightening," the U.S. Food and Drug Association on Friday cleared the experimental release of genetically modified mosquitoes in Key Haven, Florida.
Pivoting off of the recent news that there is an outbreak of the mosquito-borne Zika virus that has infected over a dozen people in Miami's Wynwood neighborhood, the UK-based developers of the genetically modified organism (GMO) reportedly also called on the FDA to grant emergency authorization to release the insects in Miami.
Oxitec, which produces other GMO products like "Arctic" apples and "AquaBounty" salmon, has developed what they describe as "self-limiting mosquitoes," genetically engineered to die before reaching adulthood.
As the company explains, Oxitec has genetically engineered male mosquitoes--known as OX513A males--which it will release into the wild to mate with native female Aedes aegypti, which bite and can potentially spread disease. Their offspring die off, reducing the population.
"Releasing GMO mosquitoes into the environment without long term environmental impact studies is irresponsible and frightening," said Zen Honeycutt, director of the anti-GMO group Moms Across America, in a statement on Saturday. "What about the creatures who eat the mosquitoes and all the life forms up the food chain? The impact could be irreversible... Allowing uncontrollable genetically altered life forms into the wild is not justified."
The Key Haven trial would run for between six and 22 months and the company said it could release anywhere from 20 to 100 mosquitoes per person on the island.
However, they must contend with strong local opposition first.
Residents of Key Haven will have the chance to vote in November on a non-binding ballot measure on the GMO trial, and a majority of the community's commissioners said they would abide by the will of the voters. And over 168,000 people have signed a petition calling on government officials to reject the trial.